Stock Analysis

UltraTech Cement delivers a Q4 beat; cost pressures keep analysts wary

UltraTech Cement posts strong Q4FY26 results, but analysts stay cautious due to cost pressures, capacity expansion risks, and sector headwinds

Lack of growth visibility at Organon could cap Sun Pharma's gains

Sun Pharma's Organon deal lifts stock, but growth concerns and high debt at the acquired firm may cap upside despite synergy potential

Reliance Industries stock likely to take a hit after muted Q4 show

Weak O2C performance drives analysts to cut target price, earnings estimates even as valuation helps retain 'buy' ratings

Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential

Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook

IKS Health shares jump 9% on TruBridge acquisition; deal seen EPS accretive

IKS Health shares surged 9.5 per cent after announcing a $557-million TruBridge acquisition. The deal, it said, will boost EPS outlook, add EHR SaaS, and unlock $575-million cross-sell potential

InCred Equities initiates on Techno Electric with 'Buy', eyes 34% upside

Techno Electric & Engineering Company is a leading EPC player in India's power transmission and distribution sector with over 45 years of experience and a proven track record across major projects

Axis Securities initiates on Jubilant Ingrevia with 'Buy', sees 21% upside

Jubilant is going through a strategic transformation from a commodity-heavy business to a specialised niche player, aiming to increase the share of speciality products across segments

Elara initiates on Sagility with Buy; sees long growth runway, 26% upside

Elara Capital expects Sagility to report revenue and earnings CAGRs of 13.9 per cent and 20.0 per cent, respectively, in INR terms over FY26E-FY28E

The Batra Hedge Framework: A Smarter Way to Think About Investing

.

Antique initiates on Flair Writing Industries with 'Buy', sees 60% upside

Antique has initiated coverage on Flair Writing Industries with a target price of ₹520, valuing the stock at 26x FY28 estimated earnings

Dixon Tech stock: MOFSL sees 30% upside, flags near-term margin pressure

Motilal Oswal sees 30% upside in Dixon Technologies share price despite near-term headwinds from weak smartphone demand and rising costs. The brokerage has reiterated 'Buy' with ₹14,700 target price

Groww share price soars 43% thus far in April; BofA sees more upside

BofA sees scope for re-rating as Groww drives further margin expansion, and establishes a credible present in wealth management

Dabur faces growth headwinds as rural demand, costs cloud outlook

Weak monsoon fears, West Asia turmoil, and rising costs cloud outlook

Jefferies downgrades Indus Towers to 'Underperform'; sees 14% downside

Jefferies has downgraded Indus Towers shares to 'Underperform', cutting target price to ₹375. The global brokerage stated renewal risks, rising capex, and pressure on earnings and valuations as risks

Stock rerating for Godrej Properties hinges on sustaining sales momentum

The stock gained 1.6 per cent on Friday after reporting its fourth quarter (Q4) numbers but slipped on Monday

Sarda Energy gains 5% after HDFC Sec initiates coverage with 'buy' rating

Stock up 14% year-to-date even as Nifty has declined nearly 9%

Emkay Global initiates on Avenue Supermarts with 'Sell', sees 16% downside

DMart is unlikely to see meaningful same-store sales growth improvement, except for seasonal fluctuations and possible price hikes by brands, given the competitive intensity in the sector

Axis Securities initiates on Aurionpro Solutions with Buy, sees 30% upside

Aurionpro Solutions has delivered around 33 per cent CAGR in revenue over FY21-25, supported by improved operational efficiency and sustained product development

Sun Pharma stock falls 5% in strong market: What's worrying investors?

Sun Pharma shares fall 5 per cent amid Organon deal buzz and US tariff concerns. Tech charts show the stock has a 'bearish' outlook